Skip to content

CHALLENGING SCIENCE. CHANGING LIVES.

Amylin Pharmaceuticals is an exceptional company of extraordinary people. Their willingness to challenge conventional thinking as much as they challenge themselves, their resolve, resiliency and passion for the patient are improving the lives of millions.

The men and women of Amylin are discovering, developing, and bringing to market innovative therapies with life-changing potential for people struggling with diabetes and obesity—merging epidemics that are fast becoming the major health crises of our lifetime. In the process, they are building an exciting new franchise in the treatment of metabolic disease and a pipeline of possibilities for future healthcare solutions.

PATIENTS

Patient StoriesAmylin is making a difference for patients. Read our Patient Stories.
Learn More

INVESTORS

Thumb: InvestorsView and download Amylin's 2008 Annual Report.
Learn More

NEWS & EVENTS

  • Jan 27

    Amylin Pharmaceuticals Reports 2009 Financial Results Full Story

  • Jan 20

    Amylin Pharmaceuticals to Webcast Year-End Financial Results Full Story

View All

  • Jan 27

    Q4 2009 Amylin Pharmaceuticals, Inc. Earnings Conference Call Full Story

  • Jan 11

    Amylin Pharmaceuticals, Inc. at JPMorgan Healthcare Conference Full Story

View All

SPOTLIGHT

Image: SymlinPen™

BYETTA® Approved for Expanded Use.
For more information, click here.